TNF-binding protein ameliorates inhibition of skeletal muscle protein synthesis during sepsis

American Journal of Physiology - Endocrinology and Metabolism

Volumn 276, Issue 4 39-4, 1999, Pages

  Cooney, Robert ^a   Kimball, Scot R ^a   Eckman, Rebecca ^a   Maish III, George ^a   Shumate, Margaret ^a   Vary, Thomas C ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Eukaryotic initiation factors; Gastrocnemius; P70(S6) kinase; Tumor necrosis factor

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; MUSCLE PROTEIN; S6 KINASE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; MALE; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RAT; SEPSIS; SKELETAL MUSCLE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032924824     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.276.4.e611     Document Type: Article

References (44)

1. Breuillé, D., M. C. Farge, R. Rosé, M. Arnal, D. Attaix, and C. Obled. Pentoxifylline decreases body weight loss and muscle protein wasting characteristic of sepsis. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E660-E666, 1993.
2. Brown, E. J., P. A. Beal, C. T. Keith, J. Chen, T. B. Shin, and S. L. Schreiber. Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature 377: 441-446, 1995.
3. Charters, Y., and R. F. Grimble. Effect of recombinant human tumour necrosis factor a on protein synthesis in liver, skeletal muscle and skin of rats. Biochem. J. 258: 493-497, 1989.
4. Chung, J., C. J. Kuo, G. R. Crabtree, and J. Blenis. Rapamycin-FKBP specifically blocks growth dependent activation of and signaling by the 70 kDa S6 protein kinases. Cell 69: 1227-1236, 1992.
5. Cooney, R., J. Iocono, G. Maish, J. S. Smith, and P. Ehrlich. Tumor necrosis factor mediates impaired wound healing in chronic abdominal sepsis. J. Trauma 42: 415-420, 1997.
6. Cooney, R., S. R. Kimball, and T. C. Vary. Regulation of skeletal muscle protein turnover during sepsis: mechanisms and mediators. Shock 1: 1-16, 1997.
7. Dardevet, D., C. Sornet, T. Vary, and J. Grizard. Phosphati-dylinositol 3-kinase and p70 S6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor I. Endocrinology 137: 4087-4094, 1996.
8. Doherty, G. M., J. C. Jensen, H. R. Alexander, C. M. Buresh, and J. A. Norton. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 111: 192-198, 1991.
9. Espat, N. J., J. C. Cenden, E. A. Bierle, T. A. Auffenberg, J. Rosenberg, D. A. Russell, J. S. Kenney, E. Fischer, W. Montegut, S. F. Lowery, E. M. Copeland III, and L. L. Moldawer. PEG-BP-30 monotherapy attenuates the cytokine-mediated inflammatory cascade in baboon Escherichia coli septic shock. J. Surg. Res. 59: 153-168 ,1995.
10. Farrari, S., and G. Thomas. S6 phosphorylation and the p70(s6k)/p85(s6k). Crit. Rev. Biochem. Mol. Biol. 29: 385-413, 1994.
11. Fattori, E., M. Cappelleti, P. Costa, C. Sellito, L. Cantori, M. Carelli, R. Faggioni, G. Fantuzzi, P. Ghezzi, and V. Poli. Defective inflammatory response in interleukin-6 deficient mice. J. Exp. Med. 180: 1243-1250, 1993.
12. Fong, Y., L. L. Moldawer, M. Marano, H. Wei, A. Barber, K. Manogue, K. J. Tracey, G. Kuo, D. A. Fischman, A. Cerami, and S. F. Lowry. Cachectin/TNF or IL-1α induces cachexia with redistribution of body proteins. Am. J. Physiol. 256 (Regulatory Integrative Comp. Physiol. 25): R659-R665, 1989.
13. Flores, E. A., B. R. Bistrian, J. J. Pomposelli, C. A. Dinarello, G. L. Blackburn, and N. W. Istfan. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. J. Clin. Invest. 83: 1614-1622, 1989.
14. Frost, R. A., C. H. Lang, and M. C. Gelato. Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology 138: 4153-4159, 1997.
15. Giroir, B. P., and B. Beutler. Effect of amrinone on tumor necrosis factor production in endotoxin shock. Circ. Shock 36: 200-207, 1992.
16. Hale, K. K., C. G. Smith, S. L. Baker, R. W. Vanderslice, C. H. Squires, T. M. Gleason, K. K. Tucker, T. Kohno, and D. A. Russell. Multifunctional regulation of the biological effects of TNF-α by soluble type I and type II TNF receptors. Cytokine 7: 26-38, 1995.
17. Hoshino, E., C. Pichard, C. E. Greenwood, G. C. Kuo, R. G. Cameron, R. Kurian, J. P. Kearns, J. P. Allard, and K. N. Jeejeebhoy. Body composition and metabolic rate in rat during a continuous infusion of cachectin. Am. J. Physiol. 260 (Endocrinol. Metab. 23): E27-E36, 1991.
18. Jefferies, H. J. B., C. Reinhrd, S. C. Kozma, and G. Thomas. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc. Natl. Acad. Sci. USA 91: 4441-4445, 1994.
19. Jurasinski, C. V., L. Kilpatrick, and T. C. Vary. Amrinone prevents muscle protein wasting during chronic sepsis. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E491-E500, 1995.
20. Llovera, M., F. J. Lopez-Soriano, and J. M. Argiles. Chronic tumor necrosis alpha treatment modifies protein turnover in rat tissues. Biochem. Mol. Biol. Int. 30: 29-36, 1993.
21. Kimball, S. R., A. M. Karinch, R. C. Feldhoff, H. Mellor, and L. S. Jefferson. Purification and characterization of eukaryotic translational initiation factor, eIF2B from liver. Biochim. Biophys. Acta 1201: 473-481, 1994.
22. Kimball, S. R., T. C. Vary, and L. S. Jefferson. Age-dependent decrease in the amount of eukaryotic initiation factor 2 in various rat tissues. Biochem. J. 286: 263-268, 1992.
23. Kohno, T., M. T. Brewee, S. L. Baker, and P. E. Schwartz. A second tumor necrosis receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA 78: 8331-8335, 1990.
24. Kozma, S. C., and G. Thomas. p70s6k/p85s6k: Mechanism of activation and role in mitogenesis. Cancer Biol. 5: 255-266, 1994.
25. Moldawer, L. L., G. Svaninger, J. Gelin, and K. G. Lundholm. Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle. Am. J. Physiol. 253 (Cell Physiol. 22): C766-C773, 1987.
26. Nakatani, T., T. Sato, L. Marzella, F. Hirai, F. B. Trump, and J. H. Siegel. Hepatic and systemic metabolic response to aerobic and anaerobic intra-abdominal abscesses in a highly reproducible chronic rat model. Circ. Shock 13: 271-294, 1984.
27. Preedy, V. R., L. Paska, P. H. Sugden, and P. Garlick. The effects of surgical stress and short-term fasting on protein synthesis in vivo in diverse tissues of the mature rat. Biochem. J. 250: 179-188, 1988.
28. Roth, J., D. Martin, B. Storr, and E. Zeisberger. Neutralization of pyrogen-induced tumour necrosis factor by its type 1 soluble receptor in guinea-pigs: effects on fever and interleukin-6 release. J. Physiol. (Lond.) 509: 267-275, 1998.
29. Russell, D. A., K. K. Tucker, N. Chinookoswong, R. Thompson, and T. Kohno. Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: improved survival and organ function. J. Infect. Dis. 171: 1528-1538, 1995.
30. Sakuri, Y., X.-J. Zhang, and R. R. Wolfe. Effect of tumor necrosis factor on substrate and amino acid kinetics in conscious dogs. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E936-E945, 1994.
31. Solorzano, C. C., A. Kaibara, P. J. Hess, P. D. Edwards, R. Ksontini, A. Abouhamze, S. McDaniel, J. Frazier, D. Trujillo, G. Kieft, J. Seely, T. Kohno, M. E. Cosenza, M. Clare-Salzler, S. L. D. MacKay, S. W. Martin, L. L. Moldawer, and C. K. Edwards. Pharmacokinetics, immunogenicity, and efficacy of dimeric TNFR binding proteins in healthy and bacteremic baboon. J. Appl. Physiol. 84: 1119-1130, 1998.
32. Tracey, K. J., S. Morgello, B. Koplin, T. J. Fahey III, J. Fox, A. Aledo, K. R. Manogue, and A. Cerami. Metabolic effects of cachetin/tumor necrosis factor are modified by site of production. J. Clin. Invest. 86: 2014-2024, 1990.
33. Van Zee, K. J., T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89: 4845-4849, 1992.
34. Vary, T. C. Regulation of skeletal muscle protein turnover during sepsis. Curr. Opin. Clin. Nutr. 1: 217-224, 1998.
35. Vary, T. C., D. Dardevet, J. Grizard, L. Voisin, C. Buffiere, P. Denis, D. Breuille, and C. Obled. Differential regulation of skeletal muscle protein turnover by insulin and IGF-I after bacteremia. Am. J. Physiol. 275 (Endocrinol. Metab. 38): E584-E593, 1998.
36. Vary, T. C., C. Jurasinski, and S. R. Kimball. Reduced 40S initiation complex formation in skeletal muscle during sepsis. Mol. Cell. Biochem. 178: 81-86, 1998.
37. Vary, T. C., C. V. Jurasinski, A. M. Karinch, and S. R. Kimball. Regulation of eukaryotic initiation factor-2 expression during sepsis. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E193-E201, 1994.
38. Vary, T. C., and S. R. Kimball. Regulation of hepatic protein synthesis in chronic inflammation and sepsis. Am. J. Physiol. 262 (Cell Physiol. 31): C445-C452, 1992.
39. Vary, T. C., J. H. Siegel, T. Nakatani, T. Sato, and H. Aoyama. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am. J. Physiol. 250 (Endocrinol. Metab. 13): E634-E640, 1986.
40. Vary, T. C., J. H. Siegel, R. Placko, B. D. Tall, and J. G. Morris. Effect of dichloroacetate on plasma and hepatic amino acids in sterile inflammation and sepsis. Arch. Surg. 124: 1071-1077, 1989.
41. Vary, T. C., J. H. Siegel, B. D. Tall, and J. G. Morris. Role of anaerobic bacteria in intra-abdominal sepsis abscesses in mediating septic control of skeletal muscle glucose oxidation and lactic acidemia. J. Trauma 29: 1003-1014, 1989.
42. Vary, T. C., L. Voisin, and R. N. Cooney. Regulation of peptide-chain initiation in muscle during sepsis by interleukin-1 receptor antagonist. Am. J. Physiol. 271 (Endocrinol. Metab. 34): E513-E520, 1996.
43. Voisin, L., K. Gray, K. M. Flowers, S. R. Kimball, L. S. Jefferson, and T. C. Vary. Altered expression of eukaryotic initiation factor 2B in skeletal muscle during sepsis. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E43-E50, 1996.
44. Zamir, O., P. O. Hasselgren, S. K. Kunkel, J. Frederick, T. Hagasigushi, J. E. Fischer. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch. Surg. 127: 170-174, 1992.